Terpenoids found in the umbelliferae family act as agonists/antagonists for ER(alpha) and ERbeta: differential transcription activity between ferutinine-liganded ER(alpha) and ERbeta.
Phytoestrogens are assumed to affect the endocrine system of animal species similarly to other man-made endocrine disrupters and to exert their effects through estrogen receptors, specifically ER(alpha) and ERbeta. However, these molecular mechanisms are not fully understood. In this study, 19 phytochemicals were surveyed for agonist and antagonist activities of ER(alpha) and ERbeta using an ERE-luciferase reporter assay. The results showed that ferutinine is an agonist for ER(alpha) and an agonist/antagonist for ERbeta, tschimgine is an agonist for both ER(alpha) and ERbeta, and tschimganidine is an agonist for only ER(alpha). Ferutinine and tschimganidine are sesquiterpenoids, and tschimgine is a monoterpenoid derived from the Umbelliferae family. A competitive binding assay showed that ferutinine has higher binding affinities than tamoxifen for both ERs. Co-transfections of coactivators such as SRC-1, TIF2, AIB1, and TRAP220 in 293T cells and use of the luciferase assay revealed that TRAP220 failed to enhance the transcription mediated by ERbeta in the presence of ferutinine. Moreover, a GST pull-down assay showed that TRAP220 marginally bound to ERbeta ligand binding domain in the presence of ferutinine. These results suggest that the conformation of ferutinine-liganded ERbeta is difficult for TRAP220 to recognize. Taken together, this suggests that some terpenoids can modulate estrogen signaling as ER subtype-selective phytoestrogens similar to SERMs (selective estrogen receptor modulators).
Ikeda
Kazuhiro
K
Department of Health Science, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi-machi, Kawachi-gun, Tochigi 329-0498, Japan.
Arao
Yukitomo
Y
Otsuka
Hiroko
H
Nomoto
Satoshi
S
Horiguchi
Hyogo
H
Kato
Shigeaki
S
Kayama
Fujio
F
D019661:Apiaceae; D001565:Benzoates / Q000378:metabolism / Q000494:pharmacology*; D001643:Bridged Bicyclo Compounds / Q000378:metabolism / Q000494:pharmacology; D002352:Carrier Proteins / Q000502:physiology; D002460:Cell Line; D003508:Cycloheptanes; D020847:Estrogen Receptor Modulators / Q000378:metabolism / Q000494:pharmacology*; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004968:Estrogens, Non-Steroidal / Q000378:metabolism / Q000494:pharmacology*; D017930:Genes, Reporter; D006801:Humans; D062385:Hydroxybenzoates / Q000378:metabolism / Q000494:pharmacology; D007529:Isoflavones; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D056913:Mediator Complex Subunit 1; D048789:Phytoestrogens; D028321:Plant Preparations; D011960:Receptors, Estrogen / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012717:Sesquiterpenes; D014157:Transcription Factors; D014158:Transcription, Genetic; D015533:Transcriptional Activation
D001565:Benzoates; D001643:Bridged Bicyclo Compounds; D002352:Carrier Proteins; D003508:Cycloheptanes; D020847:Estrogen Receptor Modulators; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004968:Estrogens, Non-Steroidal; D062385:Hydroxybenzoates; D007529:Isoflavones; C538855:MED1 protein, human; D056913:Mediator Complex Subunit 1; D048789:Phytoestrogens; D028321:Plant Preparations; D011960:Receptors, Estrogen; D012717:Sesquiterpenes; D014157:Transcription Factors; C449651:tschimgin; C449652:tschimganidin; C111068:4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en; D008156:Luciferases